191 related articles for article (PubMed ID: 32064600)
21. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
[TBL] [Abstract][Full Text] [Related]
22. VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer.
Zhang Y; Shen H; Withers HG; Yang N; Denson KE; Mussell AL; Truskinovsky A; Fan Q; Gelman IH; Frangou C; Zhang J
Sci Rep; 2017 Jul; 7(1):6190. PubMed ID: 28733631
[TBL] [Abstract][Full Text] [Related]
23. Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression.
Huang YS; Chang CC; Lee SS; Jou YS; Shih HM
Oncotarget; 2016 Jul; 7(28):43256-43266. PubMed ID: 27248326
[TBL] [Abstract][Full Text] [Related]
24. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
25. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R
Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
[TBL] [Abstract][Full Text] [Related]
27. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.
Jia Y; Shi H; Cao Y; Feng W; Li M; Li X
Life Sci; 2019 Sep; 233():116715. PubMed ID: 31376371
[TBL] [Abstract][Full Text] [Related]
28. Extracellular Visfatin-Promoted Malignant Behavior in Breast Cancer Is Mediated Through c-Abl and STAT3 Activation.
Hung AC; Lo S; Hou MF; Lee YC; Tsai CH; Chen YY; Liu W; Su YH; Lo YH; Wang CH; Wu SC; Hsieh YC; Hu SC; Tai MH; Wang YM; Yuan SS
Clin Cancer Res; 2016 Sep; 22(17):4478-90. PubMed ID: 27036136
[TBL] [Abstract][Full Text] [Related]
29. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
30. Expression status of Zic family member 2 as a prognostic marker for oral squamous cell carcinoma.
Sakuma K; Kasamatsu A; Yamatoji M; Yamano Y; Fushimi K; Iyoda M; Ogoshi K; Shinozuka K; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
J Cancer Res Clin Oncol; 2010 Apr; 136(4):553-9. PubMed ID: 19784848
[TBL] [Abstract][Full Text] [Related]
31. MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer.
Pakala SB; Rayala SK; Wang RA; Ohshiro K; Mudvari P; Reddy SD; Zheng Y; Pires R; Casimiro S; Pillai MR; Costa L; Kumar R
Cancer Res; 2013 Jun; 73(12):3761-70. PubMed ID: 23580571
[TBL] [Abstract][Full Text] [Related]
32. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
Roy R; Dagher A; Butterfield C; Moses MA
Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
[TBL] [Abstract][Full Text] [Related]
33. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling.
Kim MJ; Lim J; Yang Y; Lee MS; Lim JS
Cancer Lett; 2014 Nov; 354(1):33-42. PubMed ID: 25153349
[TBL] [Abstract][Full Text] [Related]
34. Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells.
Giordano C; Vizza D; Panza S; Barone I; Bonofiglio D; Lanzino M; Sisci D; De Amicis F; Fuqua SA; Catalano S; Andò S
Mol Oncol; 2013 Jun; 7(3):379-91. PubMed ID: 23228483
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of DPF3 promotes the proliferation and motility of breast cancer cells through activating JAK2/STAT3 signaling.
Lin WH; Dai WG; Xu XD; Yu QH; Zhang B; Li J; Li HP
Biochem Biophys Res Commun; 2019 Jun; 514(3):639-644. PubMed ID: 31076105
[TBL] [Abstract][Full Text] [Related]
36. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
[No Abstract] [Full Text] [Related]
37. Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer.
Zhang DZ; Chen BH; Zhang LF; Cheng MK; Fang XJ; Wu XJ
Oncol Res; 2017 Nov; 25(9):1453-1462. PubMed ID: 28276310
[TBL] [Abstract][Full Text] [Related]
38. NEAT1/miR‑124/STAT3 feedback loop promotes breast cancer progression.
Pang Y; Wu J; Li X; Wang C; Wang M; Liu J; Yang G
Int J Oncol; 2019 Sep; 55(3):745-754. PubMed ID: 31322202
[TBL] [Abstract][Full Text] [Related]
39. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
40. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R
Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
